Over 90 Total Lots Up For Auction at One Location - WA 04/08

Oncora Medical to power Mass General's Pediatric Proton/Photon Consortium Registry to fight pediatric cancer with data

Press releases may be edited for formatting or style | December 28, 2020 Health IT Rad Oncology
BOSTON, Mass. and PHILADELPHIA, Pa., Dec. 22, 2020 /PRNewswire/ -- Oncora Medical, an oncology data and software company, has been selected to power the Pediatric Proton/Photon Consortium Registry (PPCR), run out of the Mass General Cancer Center (MGCC), with their Oncora Analytics software platform. The PPCR is a consented registry for pediatric cancer patients with the goal of enabling more rapid research into the impact of advanced treatments such as proton therapy on children suffering from cancer. The current list of participating cancer centers includes many of the top centers in the US such as MD Anderson, the University of Pennsylvania, Northwestern Chicago Proton Center, Washington University, and the University of Florida. Oncora Analytics, which is in use at other cancer centers and systems across the US including MD Anderson and Northwell Health, integrates data from disparate oncology data sources and organizes that data to help doctors and researchers search for new cures and enhance patient care.

The project will be led by Dr. Torunn Yock, Director of Pediatric Radiation Oncology at MGCC and Professor of Radiation Oncology at Harvard Medical School, and Dr. David Lindsay, Oncora's Chief Executive Officer and co-founder. The teams have already started implementation and plan to share research updates in Q3 of 2021. Dr. Yock, when asked about the partnership, said

"We look forward to the potential of Oncora's team and technology to help us accelerate pediatric cancer research across our network of participating cancer centers. Oncora's ability to process every conceivable type of medical data, combined with their team's clinical knowledge and deep understanding of oncology makes them unique."
stats
DOTmed text ad

Reveal Mobi Pro now available for sale in the US

Reveal Mobi Pro integrates the Reveal 35C detector with SpectralDR technology into a modern mobile X-ray solution. Mobi Pro allows for simultaneous acquisition of conventional & dual-energy images with a single exposure. Contact us for a demo at no cost.

stats
Pediatric cancer impacts nearly 15,000 children per year and is the second-leading cause of death in children under the age of 14. While improvements in treatment have increased the survival rates of many childhood cancers, symptoms from treatment can persist.

When asked about his company's role in the project, Dr. Lindsay replied, "Working with registries such as the PPCR is a great opportunity to apply Oncora's technology at scale to accelerate research for a great cause. Our goal is to fight cancer with data, which certainly includes helping high powered clinical research teams improve outcomes for pediatric cancer patients. We look forward to this collaboration with Dr. Yock and her team at the PPCR."


About PPCR / Mass General

You Must Be Logged In To Post A Comment